- $696.47m
- $1.83bn
- 20
- 41
- 49
- 30
Annual balance sheet for Prokidney, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 4.58 | 20.6 | 490 | 363 |
Net Total Receivables | — | — | — | 1.38 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 5.58 | 27.3 | 505 | 374 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 10.5 | 12.6 | 13.1 | 46.4 |
Net Intangible Assets | ||||
Total Assets | 16.7 | 40.3 | 518 | 421 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 5.5 | 12.3 | 10.9 | 25 |
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 6.84 | 13.4 | 1,615 | 1,524 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 9.86 | 26.9 | -1,097 | -1,103 |
Total Liabilities & Shareholders' Equity | 16.7 | 40.3 | 518 | 421 |
Total Common Shares Outstanding |